“The role of CDMOs is already critical — and this level of ambiguity makes it all the more critical.” Ryan Kelly, Interim CEO of Rx-360, has spent years helping pharmaceutical manufacturers and their supply chain partners prepare for the unexpected.
“83% of the top 100 most prescribed generic medicines in the US have no domestic manufacturing source for their API.” — Charles Lyon, VP Manufacturing, Procurement & Logistics, API Innovation Center And yet the capacity to produce these APIs already
WuXi XDC Cayman Inc. has announced a strategic collaboration with Earendil Labs focused on its proprietary WuXiTecan-2 payload-linker technology platform for antibody-drug conjugates (ADCs). The agreement grants Earendil Labs an exclusive global licence to the technology for use against multiple
IDT Biologika has announced that it has been selected, together with SK bioscience and Australian biotechnology company Vaxxas, for Phase 1 of a next-generation vaccine development initiative managed by the European Health and Digital Executive Agency (HaDEA) on behalf of
Quotient Sciences has announced an extended commercial supply partnership with Ipsen to manufacture Sohonos (Palovarotene), a treatment for Fibrodysplasia Ossificans Progressiva (FOP), an ultra-rare disease affecting fewer than 1,000 patients globally. Sohonos was approved by the FDA in 2023 and
Scinai Immunotherapeutics Ltd. has announced that its project to advance a robotic aseptic fill & finish platform has received expanded support from the Israel Innovation Authority (IIA). The company will now utilise the full approved grant budget of NIS 5
Charles River Laboratories International, Inc. has announced definitive agreements to divest certain European Discovery Services assets and its CDMO and Cell Solutions businesses as part of the actions outlined in a strategic review conducted last year. The transactions are expected
“Managing a radiopharmaceutical supply chain is like transporting a block of ice in the middle of summer under the scorching sun in the desert—you have no means to protect it or cover it, so it just continues melting.” Daniel Rossetto,
A coalition of 15 Democratic-led states filed a federal lawsuit Tuesday against the U.S. Department of Health and Human Services and Health Secretary Robert F. Kennedy Jr., seeking to reverse the CDC’s January 2026 decision to eliminate universal immunization recommendations
Cellipont Bioservices, a cell therapy contract development and manufacturing organization (CDMO), has announced a strategic collaboration with Soter Bio, a CDMO specializing in RNA and RNA–lipid nanoparticle manufacturing for research and GMP applications. The companies will provide coordinated manufacturing pathways
